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Introduction
The first book on pediatrics in the Western world was published in 1544 AD by Thomas Phaer
(1510–1560) – a truly assiduous Renaissance man of sagacity – physician, lawyer, poet, philosopher,
and father of English pediatrics (1). However, sustained interest in diseases of children has come
over the past two centuries as attention before that was primarily, and certainly continues to be, with
diseases of adults (2, 3). Prior to this, medical care for children was provided by midwives, families,
and family friends (2). As progress was made in various organs of the human, knowledge about the
kidneys gradually arose. Much information was gained in both adult and pediatric nephrology in
the twentieth century. One concept for the primary care clinician to consider is where is the field of
pediatric nephrology going and what is the role of primary care in this regard?
Twenty-First Century: Future Directions
As we carefully cast our eyes though the keyhole of science, one can see more wondrous advances in
nephrology as this twenty-first century unwinds based on the work of previous scholars (Table 1)
(2, 4). More understanding will develop in the complex interactions of vitamin D and the kidney
based on the 1973 synthesis of 1,25(OH)2 vitamin D (4–6). Rickets was identified in the first
part of the twentieth century and research on this defective disorder of mineralization will reach
further progress (4). Mutations in podocyte genes were shown in the twentieth century to lead to
renal dysfunction from hereditary podocytopathies that has opened up an active vein of study in
this century (4, 7). The twentieth century Human Genome Project (HGP) has energized intense
inquisition on genetic causes of renal disease and genetic testing in renal disease in this century with
work on total human exome capture, next-generation sequencing, gene regulatory networks (GRN),
genome-wide association studies (GWAS), the role of micro-RNAs (miRNAs) in renal disease,
genotype-based risk prediction, and individualized genetic treatments (4, 8–11).
Modern science will continue its hunt for understanding of renal disorders by looking at twenty-
first century progress in cell biology, epigenetics, metabolomics, proteomics, pharmacogenomics,
other “omics,” integrins, inflammasomes, autophagy, stem cells, biomarkers, and other examples of
Research and Development (12–20). At the turn of the twenty-first century, research revealed that
the study of proteomics was being used to classify defects in such renal conditions as congenital
nephrotic syndrome (NS), renal hypomagnesia, and Alport syndrome variants. Ion channel muta-
tionswere identified in the early 1990s as etiologically implicated in various renal tubular syndromes,
nephrogenic diabetes, and polycystic renal disease; this erudite exploration will continue (4).
Simultaneous cognizance of diabetes from Areteus of Capadocia (81–138 AD – “melting away of
flesh into urine”) and renal physiology over the eons have lead to twentieth and now twenty-first
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TABLE 1 | Evolving twenty-first century progress in nephrology.
AIDS nephropathy
Anti-inflammatory disease and treatments
Antecedents of adult renal disease
Continuous ambulatory peritoneal dialysis (CAPD) vs. APD in children
Diabetic nephropathy
Genetic and genomic techniques/genetics (single gene disorders)
Hypertension and the kidney
Ion channel mutations
Molecular and cell biology
Nephrotic syndrome
Others (see text)
Pediatric kidney transplantation and graft rejection
Podocytopathies
Proteomics
Rickets
Stem cell therapies
Tissue engineering and regenerative medicine
Vitamin D and the kidney (proximal tubule interactions and others)
century research on diabetic kidney disease that will advance (21).
Cross-over investigations between the current and past centuries
include exploration of the cause andmanagement of hypertension
and its connection to renal physiology as well as the impact of the
twenty-first century epidemic on obesity (22). Another cross-over
epidemic from the previous century to the present one that will
continue is AIDS/HIV, including AIDS nephropathy that was first
identified in the 1980s (23).
Continuous ambulatory peritoneal dialysis (CAPD) in chil-
dren was identified in the 1970s and 1980s; its usefulness will
be studied further now and well into this century – in relation
to such issues as risk (i.e., peritonitis) and automated peritoneal
dialysis (APD) (24). Challenges and benefits of pediatric renal
transplantation will persevere to occupy researchers in pediatric
and adult nephrology (25). This exigent endeavor includes proto-
cols for minimal utilization of steroids and calcineurin inhibitors,
improved anti-HLA antibodies diagnosis, and innovative meth-
ods to reduce early acute rejection and graft loss (25). Trans-
plantation problems continue including donor organ shortage,
graft failure, andmany complications. Research in the twenty-first
century is looking at cell-based tools that utilize tissue engineering
and regenerative medicine to allow replacement of dysfunctional
renal cells with normally functioning cells and subsequent nor-
malization of renal activity (26).
Research will also advance issues that initiated the field of
pediatric nephrology in the latter half of the twentieth century –
including improved diagnosis and management of acute kid-
ney injury (AKI), polycystic kidney disease, vesicoureteral reflux
(VUR), and the NS (27). For example, work continues in AKI with
reference to its early identification and its relation to hemody-
namic resuscitation protocols. An algorithm has been developed
to serve as a beneficial diagnostic tool for primary care clinicians
with regard to early diagnosis and management of renal cystic
disease. Studies are also examining current protocols inVURdiag-
nosis and management. After hundreds of years of dealing with
theNS inmedicine, NS remains a complex condition often subject
to relapse and remission in most patients despite management in
the twenty-first century (27).
Primary Care: A Need for Insightful
Information
The current and future shortage of pediatric nephrologists neces-
sitates steady, rejuvenated information on the pediatric kidney for
primary care clinicians as they care for the child and adolescent
with renal and genitourinary dilemmas and disorders (28–30).
As noted by a number of experts, this shortage of nephrologists,
including pediatric nephrologists, will continue into the twenty-
first century (28–30). In view of this shortage and the rapidly
increasing knowledge in pediatric nephrology as well under-
standing indications for referral to pediatric nephrologists in the
twenty-first century, useful information aimed at primary care
clinicians in these areas becomes increasingly important.
It is easy for a non-nephrologist to become lost in the complex-
ities of renal physiology, diagnosis, and treatment – i.e., to miss
the forest for the trees. In this expression, one can see so many
trees but not understand they are part of a vast forest and fail to
appreciate the forest itself.
As the primary care clinician consider themany details of pedi-
atric nephrology (the “trees”) one can fail to appreciate basic con-
cepts that they can manage (the “forest”) – as for example – effec-
tively managing potentially benign but common conditions, such
as transient proteinuria, orthostatic proteinuria, and microscopic
hematuriawithout proteinuria. If one appreciates that themajority
of kidney disease in children relates to hypertension, the primary
care physician (PCP) can be energized to persistently and carefully
monitor the blood pressure of all of his/her pediatric patients.
Early diagnosis of hypertension and careful management of all
these patients with the help of consultants is a vital and rewarding
task of primary care clinicians andwill preventmuch renal disease
in these pediatric patients. Management of dehydration is also
a critical role of clinicians (31). It is important for the PCP to
remain familiar with common scenarios in nephrology through
conferences and workshops. An interest in this field is important
as PCPs will continue to monitor many of these children as the
shortage of pediatric nephrologists will continue. The primary
care clinician who clearly sees this forest will be of immense help
to their pediatric patients and not miss the forest for the trees in
pediatric nephrology.
I’m always astonished by a forest. It makes me realize
that the fantasy of nature is much larger than my own
fantasy. I still have things to learn.
Gunter Grass (1927–2015).
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